Author:
Ender Biçer ,Mustafa Macit
Reference48 articles.
1. Pandit, U.J., Naikoo, G.A., Khan, G.A., Wankar, S., Khan, I., Raj, K.K., and Limaye, S.N., Electrochemical and spectroscopic evaluation on interaction of anticancer drug bicalutamide with DNA, Pharma Chem., 2017, vol. 9, p. 82.
2. Li, N., Ma, Y., Yang, C., Guo, L., and Yang, X., Interaction of anticancer drug mitoxantrone with DNA analysed by electrochemical and spectroscopic methods, Biophys. Chem., 2005, vol. 116, p. 199. https://doi.org/10.1016/j.bpc.2005.04.009
3. Alotaibi, S.H. and Momen, A.A., Anticancer drugs’ deoxyribonucleic acid (DNA) interactions, in Biophysical Chemistry – Advance Applications, Khalid, M.A.A., Ed., London: IntechOpen, 2019, chapter 6, pp. 1–23. https://doi.org/10.5772/intechopen.85794.
4. Wang, L., Lin, L., and Ye, B., Electrochemical studies of the interaction of the anticancer herbal drug emodin with DNA, J. Pharm. Biomed. Anal., 2006, vol. 42, p. 625. https://doi.org/10.1016/j.jpba.2006.05.017
5. Khosravi, I., Hosseini, F., Khorshidifard, M., Sahihi, M., and Rudbari, H.A., Synthesis, characterization, crystal structure and HSA binding of two new N,O,O-donor Schiff-base ligands derived from dihydroxybenzaldehyde and tert-butylamine, J. Mol. Struct., 2016, vol. 1119, p. 373. https://doi.org/10.1016/j.molstruc.2016.04.094